Published 3 days ago • loading... • Updated 3 days ago

Promising Pharmaceutical Stocks To Follow Today - October 31st

Eli Lilly and Company, Regeneron Pharmaceuticals, Johnson & Johnson, AbbVie, Gilead Sciences, Merck & Co., Inc., and Vertex Pharmaceuticals are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companie

1 Articles

MarketBeat

Center

Promising Pharmaceutical Stocks To Follow Today - October 31st

3 days ago·Sioux Falls, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated3 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States 3 days ago on Saturday, October 31, 2026.

Sources are mostly out of (0)

Promising Pharmaceutical Stocks To Follow Today - October 31st

1 Articles

1 Articles

Promising Pharmaceutical Stocks To Follow Today - October 31st

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Covid. Buonguerrieri (FdI): Count II Government Refused Free Monoclonals but Supported Friend Foundation

Tesla misled South Korean customers about automated-driving tech, consumer group alleges

AMD stock jumps 7% on earnings as data center revenue nearly doubles

The Jakarta Composite Index (JCI) Remains Stuck at 5,000, with Investors Eagerly Awaiting the Latest Data.

Ibovespa Has 6th Fall Followed with Worsening of the Domestic Scenario; Dollar Closes in the Highest Rating of the Year – Money Times

Henry Schein: Q3 Earnings Snapshot

Similar News Topics

Similar News Topics

More stories like this

Covid. Buonguerrieri (FdI): Count II Government Refused Free Monoclonals but Supported Friend Foundation

Tesla misled South Korean customers about automated-driving tech, consumer group alleges

AMD stock jumps 7% on earnings as data center revenue nearly doubles

The Jakarta Composite Index (JCI) Remains Stuck at 5,000, with Investors Eagerly Awaiting the Latest Data.

Ibovespa Has 6th Fall Followed with Worsening of the Domestic Scenario; Dollar Closes in the Highest Rating of the Year – Money Times

Henry Schein: Q3 Earnings Snapshot

Promising Pharmaceutical Stocks To Follow Today - October 31st

1 Articles

1 Articles

Promising Pharmaceutical Stocks To Follow Today - October 31st

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Covid. Buonguerrieri (FdI): Count II Government Refused Free Monoclonals but Supported Friend Foundation

Tesla misled South Korean customers about automated-driving tech, consumer group alleges

AMD stock jumps 7% on earnings as data center revenue nearly doubles

The Jakarta Composite Index (JCI) Remains Stuck at 5,000, with Investors Eagerly Awaiting the Latest Data.

Ibovespa Has 6th Fall Followed with Worsening of the Domestic Scenario; Dollar Closes in the Highest Rating of the Year – Money Times

Henry Schein: Q3 Earnings Snapshot

Similar News Topics

Similar News Topics

More stories like this

Covid. Buonguerrieri (FdI): Count II Government Refused Free Monoclonals but Supported Friend Foundation

Tesla misled South Korean customers about automated-driving tech, consumer group alleges

AMD stock jumps 7% on earnings as data center revenue nearly doubles

The Jakarta Composite Index (JCI) Remains Stuck at 5,000, with Investors Eagerly Awaiting the Latest Data.

Ibovespa Has 6th Fall Followed with Worsening of the Domestic Scenario; Dollar Closes in the Highest Rating of the Year – Money Times

Henry Schein: Q3 Earnings Snapshot

Bias Distribution

Factuality